Staging of bone tumors: A review with illustrative examples

American Journal of Roentgenology

Volumn 186, Issue 4, 2006, Pages 967-976

  Stacy, Gregory S ^a   Mahal, Ravinder S ^a,b   Peabody, Terrance D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bone cancer; Musculoskeletal imaging; Musculoskeletal system; Oncologic imaging

Indexed keywords

AMERICAN JOINT COMMITTEE ON CANCER; BONE SCINTISCANNING; BONE TUMOR; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EVALUATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; ADOLESCENT; ADULT; CHILD; FEMALE; MALE; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 33646915037     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.0654     Document Type: Review

References (36)

1. Morrison WB, Dalinka MK, Daffner RH, et al. Bone tumors. In: ACR appropriateness criteria. Reston, VA: American College of Radiology, 2005:1-5
2. Sundaram M, McLeod RA. MR imaging of tumor and tumorlike lesions of bone and soft tissue. AJR 1990; 155:817-824
3. Resnick D. Tumors and tumor-like lesions of bone: radiographic principles. In: Resnick D, ed. Diagnosis of bone and joint disorders. Philadelphia, PA: Saunders, 2002:3745-3762
4. Ardran GM. Bone destruction not demonstrable by radiography. Br J Radiol 1951; 24:107-109
5. Frank JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. AJR 1990; 155:1043-1048
6. El-Khoury GY, Bennett DL, Dalinka MK, et al. Metastatic bone disease. In: ACR appropriateness criteria. Reston, VA: American College of Radiology, 2005:1-11
7. Deely D, Schwietzer M. Imaging evaluation of the patient with suspected bone tumor. In: Taveras JM, Ferrucci JT, ed. Radiology, vol. 5. Philadelphia, PA: Lippincott Williams & Wilkins, 1998: chapter 74, pp. 1-6
8. Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin: a prospective study of a diagnostic strategy. J Bone Joint Surg Am 1993; 75:1276-1281
9. Angtuaco EJC, Fassas ABT, Walker R, Sethi R, Barlogie B. Multiple myeloma: clinical review and diagnostic imaging. Radiology 2004; 231:11-23
10. Lodwick GS, Wilson AJ, Farrell C, Virtama P, Dittrich F. Determining growth rates of focal lesions of bone from radiographs. Radiology 1980; 134:577-583
11. Zimmer WD, Berquist TH, McLeod RA, et al. Bone tumors: magnetic resonance imaging versus CT. Radiology 1985; 155:709-718
12. Hogeboom WR, Hoekstra HJ, Mooyart EL, et al. MRI or CT in the preoperative diagnosis of bone tumors. Eur J Surg Oncol 1992; 18:67-72
13. Salamipour H, Jimenez RM, Brec SL, Chapman VM, Kalra MK, Jaramillo D. Multidetector row CT in pediatric musculoskeletal imaging. Pediatr Radiol 2005; 35:555-564
14. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; 153:106-120
15. Peabody TD, Gibbs CP Jr, Simon MA. Evaluation and staging of musculoskeletal neoplasms. J Bone Joint Surg Am 1998; 80:1204-1218
16. American Joint Committee on Cancer. Bone. In: Fleming ID, Cooper JS, Henson DE, et al., eds. AJCC cancer staging manual. Philadelphia, PA: Lippincott-Raven, 1997:143-147
17. American Joint Committee on Cancer. Bone. In: Greene FL, Page DL, Fleming ID, et al., eds. AJCC cancer staging manual. New York, NY: Springer-Verlag, 2002:213-219
18. Heck RK, Stacy GS, Flaherty MJ, Montag AG, Peabody TD, Simon MA. A comparison study of staging systems for bone sarcomas. Clin Orthop Relat Res 2003; 415:64-71
19. Bloem JL, Taminiau AH, Eulderink F, Hermans J, Pauwels EK. Radiologic staging of primary bone sarcoma: MRI, scintigraphy, angiography and CT correlated with pathologic examination. Radiology 1988; 169:805-810
20. Boyko OB, Cory DA, Cohen MD, Provisor A, Mirkin D, DeRosa GP. MR imaging of osteogenic and Ewing's sarcoma. AJR 1987; 148:317-322
21. Simon MA, Kirchner PT. Scintigraphic evaluation of primary bone tumors: comparison of technetium-99m phosphonate and gallium citrate imaging. J Bone Joint Surg Am 1980; 62:758-764
22. Sundaram M. The use of gadolinium in the MR imaging of bone tumors. Semin ultrasound CT MR 1997; 18:307-311
23. May DA, Good RB, Smith DK, Parsons TW. MR imaging of musculoskeletal tumors and tumor mimickers with intravenous gadolinium: experience with 242 patients. Skeletal Radiol 1997; 26:2-15
24. Verstraete KL, Lang P. Bone and soft tissue tumors: the role of contrast agents for MR imaging. Eur J Radiol 2000; 34:229-246
25. Brisse H, Ollivier L, Edeline V, et al. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol 2004; 34:595-605
26. Reddick WE, Wang S, Xiong X, et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer 2001; 91:2230-2237
27. Egmont-Petersen M, Hogendoorn PCW, van der Geest RJ, et al. Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling. Magn Reson Imaging 2000; 18:525-535
28. Ongolo-Zogo P, Thiesse P, Sau J, et al. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy. Eur Radiol 1999; 9:907-914
29. El Khadrawy AM, Hoffer FA, Reddick WA. Ewing sarcoma recurrence vs radiation necrosis in dynamic contrast-enhanced MR imaging: a case report. Pediatr Radiol 1999; 29:272-274
30. Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001; 12:479-486
31. McKillop JH, Etcubanas E, Goris ML. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. Cancer 1981; 48:1133-1138
32. Goldstein G, McNeil BJ, Zufall E, Jaffe N, Treves S. Changing indications for bone scintigraphy in patients with osteosarcoma. Radiology 1980; 135:177-180
33. Hawkins DS, Rajendran JG, Conrad EU, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002; 94:3277-3284
34. Franzius C, Schulte M, Hillmann A, et al. Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft-tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in oncology": results of the Bone and Soft-Tissue Study Group [in German]. Chirurg 2001; 72:1071-1077
35. Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25:874-881
36. Enneking WF. Staging musculoskeletal tumors. In: Enneking WF, ed. Musculoskeletal tumor surgery. New York, NY: Churchill Livingstone, 1983:87-88